Document Type
|
:
|
BL
|
Record Number
|
:
|
872486
|
Title & Author
|
:
|
Noninvasive prenatal testing (NIPT) : : applied genomics in prenatal screening and diagnosis /\ edited by Lieve Page-Christiaens, Hanns-Georg Klein.
|
Publication Statement
|
:
|
London, UK :: Academic Press is an imprint of Elsevier,, [2018]
|
|
:
|
, ©2018
|
Page. NO
|
:
|
1 online resource (xxvii, 377 pages) :: illustrations
|
ISBN
|
:
|
0128141905
|
|
:
|
: 9780128141908
|
|
:
|
0128141891
|
|
:
|
9780128141892
|
Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
Contents
|
:
|
Section 1: Cell-freeDNA (CfDNA): overview and technology. Fetal DNA in maternal plasma: an amazing two decades -- Understanding the basics of next generation sequencing in the context of cell-free DNA based NIPT -- The technology and bioinformatics of cell-free DNA based NIPT -- Section 2: CfDNA in clinical practice. Prenatal screening for common aneuploidies before and after the introduction of cell-free DNA based NIPT -- Why cell-free DNA based NIPT for fetal chromosome anomalies is not diagnostic -- The role of cell-free DNA based NIPT in twin pregnancy -- Genomewide testing for autosomal trisomies and copy number variations -- Non-invasive fetal blood group typing -- Noninvasive prenatal diagnosis (NIPD) of monogenic disorders -- Maternal constitutional and acquired copy number variations (CNVs) -- Section 3: Clinical integration. Best practices for integrating cell-free DNA based NIPT into clinical practice -- Quality assurance and standardization of cell-free DNA based NIPT laboratory procedures -- Decisional support for expectant parents -- Cell-free DNA based NIPT and society -- Ethics of cell-free DNA based NIPT for sex chromosome aneuploidies and sex determination -- Cost-effectiveness of cell-free DNA based NIPT: summary of evidence and challenges -- Section 4: The future. Exome sequencing in the evaluation of the fetus with structural anomalies -- Cell-based NIPT: a promising path for prenatal diagnosis -- Maternal circulating nucleic acids as a marker of placental health -- Prenatal treatment of genetic diseases in the unborn
|
Abstract
|
:
|
"Since its introduction in 2012, cell-free (cf) DNA based Non-Invasive Prenatal Testing (NIPT) has been employed to test for fetal chromosome abnormalities, and gene mutations that lead to a variety of genetic conditions, by millions of pregnant women, in more than 90 countries worldwide. With Noninvasive Prenatal Testing (NIPT): Applied Genomics in Prenatal Screening and Diagnosis, Dr Lieve Page-Christiaens and Dr Hanns-Georg Klein have compiled the first authoritative volume on cfDNA NIPT methods and their clinical implementation"--Publisher's description.
|
Subject
|
:
|
Genomics.
|
Subject
|
:
|
Prenatal diagnosis.
|
Subject
|
:
|
Genomics.
|
Subject
|
:
|
MEDICAL / Gynecology Obstetrics.
|
Subject
|
:
|
Prenatal diagnosis.
|
Subject
|
:
|
Cell-Free Nucleic Acids-- analysis.
|
Subject
|
:
|
Prenatal Diagnosis-- methods.
|
Subject
|
:
|
Aneuploidy.
|
Subject
|
:
|
Chromosome Disorders-- diagnosis.
|
Subject
|
:
|
Fetal Diseases-- diagnosis.
|
Subject
|
:
|
Genetic Testing-- methods.
|
Subject
|
:
|
Maternal-Fetal Exchange.
|
Subject
|
:
|
Sequence Analysis, DNA.
|
Dewey Classification
|
:
|
618.3/2075
|
LC Classification
|
:
|
RG628
|
NLM classification
|
:
|
WQ 209
|
Added Entry
|
:
|
Klein, Hanns-Georg
|
|
:
|
Page-Christiaens, Lieve
|
Parallel Title
|
:
|
Applied genomics in prenatal screening and diagnosis
|